Introduction {#s0005}
============

Due to severe brain injury, many patients fail to recover and develop disorders of consciousness (DOC). Patients with preserved arousal but absence of any behavioral signs of awareness are diagnosed as vegetative state ([@bb0150]) ([@bb0115]); while patients of minimally conscious state (MCS) are defined as having preserved arousal and non-reflexive and purposeful behaviors ([@bb0090]). In the clinic, it is a challenge to diagnose and treat patients with DOC, and due to the costs of prolonged intensive care ([@bb0145]), DOC patients place great financial strain on families and medical structures ([@bb0180]). It has been reported that there are no evidence-based guidelines regarding the treatment of patients with disorders of consciousness ([@bb0020], [@bb0105]), even though many potential pharmacological, as well as non-pharmacological interventions have been evaluated in the last decade. The promising and growing field of neuromodulation has been proposed as a source of non-pharmacological therapeutic techniques for DOC patients. Invasive neuro-stimulation techniques, such as deep brain stimulation, have been reported to induce behavioral improvement in MCS and VS patients ([@bb0100], [@bb0245]). Recently, due to ethical and procedural limitations on the use of invasive stimulation techniques, non-invasive brain stimulation, including transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS), have been investigated for treating DOC patients ([@bb0005], [@bb0110], [@bb0275]).

It has been reported that tDCS can modulate cortical excitability in healthy people, and it is safer, less uncomfortable, easier to handle, and less expensive than TMS ([@bb0235]). Recently, it was found that tDCS is effective in treating a variety of psychiatric and neurological conditions, including depression ([@bb0050], [@bb0135]), Parkinson\'s disease ([@bb0155], [@bb0220]), autism ([@bb0055]), and epilepsy ([@bb0075], [@bb0200]). Also, the application of tDCS facilitates neuro-rehabilitation, such as post-stroke recovery ([@bb0120], [@bb0270]). At the same time, tDCS has been applied for consciousness improvement of DOC patients ([@bb0005], [@bb0275]). A double-blind sham-controlled crossover design study with anodal and sham tDCS delivered over the left DLPFC indicated a significant treatment effect in MCS patients, and several patients with MCS, as well as VS, showed post-anodal tDCS related signs of consciousness ([@bb0275]). A long duration tDCS protocol applied to MCS and VS patients showed that all patients with MCS had clinical improvement immediately after tDCS, but no patient in VS showed immediate improvement ([@bb0005]). Another study demonstrated that tDCS can boost cortical connectivity and excitability in MCS and VS patients ([@bb0185]).

In the clinic, behavioral assessment is usually applied to detect conscious awareness. Thus, the possible mechanisms of change of tDCS in DOC patients have not been studied, and the electrophysiological effects of tDCS of DOC patients are unclear. TMS-EEG has been proposed to obtain real-time and direct information about cortical reactivity as TMS-EEG can detect changes in cortical excitability/inhabitation. It has been used to assess cortical excitability in different consciousness states ([@bb0040], [@bb0065], [@bb0175]). Motor system ([@bb0210]) and central cortex ([@bb0235]) excitability induced by tDCS in healthy subjects have been effectively assessed using TMS-EEG. TMS evoked potential showed that, in healthy subjects, tDCS over the left primary motor cortex induced an enhancement of cortical excitability, whereas cathodal stimulation produced a reduction ([@bb0210]). And the anodal tDCS over parietal cortex also induced an excitability enhancement ([@bb0235]).

In this study, we propose to take advantage of TMS-EEG for assessing the cortical excitability of patients with DOC treated with tDCS, comparing before and after stimulation. We aim to demonstrate the effectiveness of tDCS on patients with DOC, which will support the use of tDCS in clinical practice.

Materials and methods {#s0010}
=====================

Participants {#s0015}
------------

We enrolled 18 patients with disorder of consciousness (9 VS and 9 MCS, 7 females and 11 males) in this study. Two of them were excluded with suspected of EEG epileptiform activity in EEG evaluation. The clinical characteristics of the others are shown in [Table 1](#t0005){ref-type="table"}. Clinical status of each patient was assessed with the JFK Coma Recovery Scale (JFK CRS-R) ([@bb0095]). And based on their CRS-R scores, patients were diagnosed as MCS and VS. All the patients had no focal lesions in frontal lobes at MRI scans, epileptic history, pacemarker, aneurysms clips, neurostimulator, or brain/ subdural electrodes. Patient VS5 and VS8 have received craniotomy surgery to reduce intracranial pressure. No one suffered craniotomy plastic surgery. All patients were stabilized with no consciousness improvement for more than one month. Patients with complications such as acute pneumonia during two weeks before the experiment were excluded. Any other treatment and drug which modifying cortical-excitability were excluded. Written informed consent to participate in the study was obtained from the patients\' caregivers and the patients. The present study was approved by the ethics committee of the PLA Army General Hospital (registration number: 2015--023).Table 1Demographic details for the patients.Table 1PatientAge&SexEtiologyMoths\
Post-injuryCRS-RAuditoryVisualMotorOro-motorCommArousalTotalVS117 mTBI71121027VS250 fAnoxia81021026VS346 mHaemorrhage91121005VS435 mAnoxia120021025VS552 mIschemic stroke81121005VS639 mHaemorrhage81121027VS760 mAnoxia131021026VS843 mTBI81010024VS970 fAnoxia301121027MCS153 mHaemorrhage833210211MCS268 mTBI1233511215MCS331 fAnoxia3523310211MCS429 fAnoxia281231029MCS549 fTBI1333310212MCS652 mAnoxia63021028MCS747 fHaemorrhage61131028[^1]

**TDCS.**

Each patient received two sessions of tDCS stimulation: one real and one sham session. The two sessions were separated by at least three days and the order was counterbalanced across patients. TDCS was delivered by an Eldith DC-stimulator (neuroConn GmbH, Ilmenau, Germany). The stimulation electrodes (25 *cm*^2^) were covered by sponges soaked with saline solution. The anodal tDCS electrode was placed over the left dorsolateral prefrontal cortex (DLPFC) centered at F3 (International 10--10 system), and the cathodal electrode was placed over the right supraorbital area, centered at FP2. For real tDCS, a constant current of 2 mA was applied for 20 min, with 15 s of fade-in/fade-out period. For sham tDCS, the same electrode arrangement and parameters for stimulation were employed, except that the stimulator was turned off after 30s ([@bb0085]).

**TMS-EEG.**

As shown in [Fig. 1](#f0005){ref-type="fig"}, patients received 200 single pulses of TMS in the left DLPFC before and immediately after the tDCS protocol with intensity of 90%RMT. The magnetic stimulation was administered in accordance with safety guidelines ([@bb0285]). TMS pulses were delivered using a Magstim *R*^2^ stimulator with a 70 mm figure-of-eight coil (Magstim Company Limited, Whitland, UK). We used a biphasic waveform with a pulse width of \~ 0.1 ms. Stimulation intensity varied across this experiment and was determined relative to the resting motor threshold (RMT), defined as the lowest TMS intensity which can evoke in at least five out of ten trials an EMG with an amplitude \> 50*μV* peak-to-peak in the relaxed first dorsal interosseous muscle of the right hand. To avoid contamination of TMS-evoked potentials by auditory potentials evoked by the click associated with the TMS discharge, patients wore inserted earplugs which continuously played a masking noise. Bone conduction was attenuated by placing a thin layer of foam between coil and scalp. The details of the TMS-EEG procedure and setup could be found in previous study ([@bb0175]). And this TMS setup has been used to evaluate cerebral excitability of a patient with DOC in her consciousness recovery ([@bb0010]).Fig. 1A schematic representation of the experimental procedure. Each experimental session began with a TMS-EEG block, 200 single pulse TMS delivered to L-DLPFC with 90%RMT intensity. Then, real or sham anodal tDCS was delivered to L-DLPFC with cathode over the right supraorbital area. Stimulation lasted 20 min, and a TMS-EEG block immediately followed.Fig. 1.

In this experiment, we used a TMS-compatible EEG recorder (BrainAmp 64 MRplus, BrainProducts). EEG was continuously acquired from 62 channels at positions of the international 10--20 system. The equipment used TMS-compatible sintered Ag/AgCl-pin electrodes. We set a band-pass filter at DC to 1000 Hz in the recorder, and the EEG signal was digitized at a sampling rate of 2.5 kHz. During the experiment, the skin/electrode impedance was maintained below 5kΩ. EEG recordings were carried out while patients were behaviorally awake (eyes open, EO), and if a patient showed signs of sleepiness (prolonged eye closure, EC), the CRS-R arousal facilitation protocol was applied, or the experiment was suspended.

**Analysis methods.**

\(1\) Preprocessing.

Off-line analysis was performed with EEGLAB 12.0.2.5b, running in a MATLAB environment (Version 2013b, MathWorks Inc., Natick, USA). The continuous EEG signal was segmented into epochs starting 300 ms before TMS pulse onset and ending 500 ms ([@bb0065], [@bb0070], [@bb0175]) after it. After this, data 10 ms before to 20 ms after the TMS pulse were removed from each trial to exclude the TMS artifact, using the cubic interpolation function of MATLAB ([@bb0280]). Independent component analysis (ICA) was used to identify the TMS unrelated artifacts (such as eye movement and muscle artifacts), by visually inspecting in terms of scalp distribution, frequency, timing, and amplitude. The components deemed as artifact were removed with ICA ([@bb0040]). The 50 Hz power-line artifact was removed from remaining trials using a notch filter. Then, EEG data were common-average referenced; down-sampled to 500 Hz, band-pass filtered (1-80 Hz), and baseline corrected over 300 ms pre-stimulus. Single trials were carefully inspected to ensure absence of residual TMS artifacts. Each TMS-evoked response was obtained by averaging 150 to 200 artifact-free trials.

\(2\) Global and local mean field amplitude.

We used global mean field amplitude (GMFA) to describe the overall TMS induced activities. The GMFA can be expressed by$$\mathit{GMFA}\left( t \right) = \sqrt{\left. \sum\limits_{i = 1}^{N}\left\lbrack {V_{i}\left( t \right) - \overset{-}{V}\left( t \right)} \right\rbrack^{2}/N. \right.}$$

where *V*~*i*~(*t*) is the signal averaged over trials measured on EEG channel *i* at time *t*, $\overset{-}{V}\left( t \right)$ is the signal averaged over trials and channels at time *t*, and *N* is the number of channels. The GMFA identifies the maximum amplitude of the evoked field and is used to index the effect of TMS on global brain activity ([@bb0130]).

Local mean field amplitude (LMFA) was calculated to investigate the change in local cortical regions. This used the same procedure as used for calculating the GMFA, except that only the channels over a cortical region were included. The brain was divided into five cortical regions: frontal (FPz, FP1, FP2, AF7, AF8, AF3, AF4, *F*1, F2, F3, *F*4), left hemisphere (F5, F7, FC3, FC5, FT7, C5, T7, CP3, CP5, TP7, P5, P7), central (Fz, FCz, FC1, FC2, Cz, *C*1, C2, C3, *C*4, CPz, CP1, CP2, Pz), right hemisphere (F6, F8, FC4, FC6, FT8, C6, T8, CP4, CP6, TP8, *P*6, P8), and posterior (*P*1, P2, *P*3, *P*4, POz, PO3, PO4, PO5, PO6, PO7, PO8, Oz, O1, O2) (See [Fig. 4](#f0020){ref-type="fig"} A). Four intervals (0-100 ms, 100-200 ms, 200-300 ms, 300-400 ms) of GMFA and LMFA, for both real and sham stimulation, were calculated.

Results {#s0020}
=======

**(1) Example of different TMS evoked potentials between a MCS and a VS patients**

[Fig. 2](#f0010){ref-type="fig"} shows the average EEG response to TMS pulses of one MCS and one VS patient, recorded at the 60 electrodes. Comparing the MCS with the VS patient (see [Fig. 2](#f0010){ref-type="fig"}. A-a, B-a), the TMS evoked potentials (TEP) are different before tDCS (pre-tDCS), with significant different TEP in the interval of 150--300 ms after the TMS pulse. The TEP before tDCS was different from the TEP after tDCS for both the MSC and VS patient (see [Fig. 2](#f0010){ref-type="fig"} A-a,b and B-a,b). For the MCS patient, the TEP within 150 ms after the TMS pulse was increased after tDCS. However the change is very weak for the VS patient, which showed some weak changes after 300 ms. Consistent with single channel signal trends, the overall GMFA of the MCS patient indicates significant activation in the first 150 ms after the TMS pulse, while power significantly decreased around 250 ms ([Fig. 2](#f0010){ref-type="fig"} (A-c)), as compared to pre-tDCS. The changes to TEP also occurred in the VS patient, and analysis of significant activation shows expanded regions for signal peaks in the first 100 ms after the TMS pulse (see [Fig. 2](#f0010){ref-type="fig"} B-c), compared to pre-tDCS. Comparison of the GMFA shows significant power increase around 100 ms and decrease after 300 ms ([Fig.2](#f0010){ref-type="fig"} B-c).Fig. 2EEG response to TMS pulses by one MCS and one VS patient. (A) Average TEP pre-tDCS and significant activation spatial patterns at each peak. (B) Average TEP post-tDCS and significant activation spatial patterns at each peak. (C) GMFA traces for pre-tDCS (blue) and post-tDCS (red). Shadow areas show plus and minus one standard deviation. Black lines above the traces indicate significance with paired *t-test*, *p* \< 0.05;Fig. 2.

\(2\) **Different global excitability induced by tDCS for MCS and VS patients**

Plots of GMFA averaged over patients are shown in [Fig. 3](#f0015){ref-type="fig"}. Two-way repeated measures ANOVA was performed in MCS and VS with time windows (4 levels: 0-100 ms, 100-200 ms, 200-300 ms and 300-400 ms) and condition (2 levels: pre-tDCS and post-tDCS) as within-subject factors, and the GMFA value as the dependent variable. Correction of the degrees of freedom was performed by using the Greenhouse-Geisser correction. Main effect of condition was found (F(1,6) = 57.88, *p* = 0.00) and interaction between condition with time windows was found (F(1.24,7.45) = 12.04, *p* = 0.008) in MCS group. Significant changes between pre- and post-tDCS were found for real tDCS stimulation in both the MCS and VS groups, while no significant changes could be found for sham stimulation. For MCS patients, pairwise comparison with multiple correction in each time windows showed significantly higher values for post-tDCS in the 0-100 ms (*p* = 0.020, FDR correction) and 100-200 ms (*p* = 0.006, FDR correction), as compared to pre-tDCS. For VS patients, significantly higher values post-tDCS compared to pre-tDCS in the 0-100 ms (*p* = 0.013, FDR correction) and significantly lower values in 300-400 ms (*p* = 0.004, FDR correction) were found.Fig. 3Mean GMFA in different time windows. (A) GMFA of MCS (left column) and VS (right column) for real stimulation. (B) GMFA of MCS (left column) and VS (right column) for sham stimulation. \* indicates *p* \< 0.05 and \*\* indicates *p* \< 0.01.Fig. 3.

\(3\) **Different local excitability induced by tDCS for MCS and VS patients**

In order to specify the spatial distribution of the tDCS induced changes in each group during the time windows which has significant changes of GMFA, the brain was divided into five regions and LMFA was calculated in each region. [Fig. 4](#f0020){ref-type="fig"} shows LMFA averaged over patients for the time windows in each group. For the MCS group, two-way repeated measures ANOVA was performed with regions (5 levels: frontal, left/right hemispheres, central, and posterior) and condition (2 levels: pre-tDCS and post-tDCS) as within-subject factors, and the LMFA value as the dependent variable. Correction of the degrees of freedom was performed by using the Greenhouse-Geisser correction. We found significant main effects of condition in the 0-100 ms (F(1,6) = 12.75, *p* = 0.012), 100-200 ms (F(1,6) = 30.74, *p* = 0.001). There was no significant main effect of regions and no interaction between regions and condition. Pairwise comparisons with multiple correction between pre-tDCS and post-tDCS in each region and time window showed significant excitability increase in frontal (*p* = 0.03, FDR correction), left hemisphere (*p* = 0.037, FDR correction), central (*p* = 0.03, FDR correction) during 0-100 ms; increase in frontal (*p* = 0.02, FDR correction) and right hemisphere (*p* = 0.033, FDR correction) during 100-200 ms.Fig. 4Mean LMFA for real stimulation. (A) Brain was divided into five regions for LMFA calculation: frontal, left hemisphere, central, right hemisphere, and posterior. (B) Mean LMFA of MCS patients in time windows of 0-100 ms and 100-200 ms for the five regions. And mean LMFA of VS patients in time windows of 0-100 ms and 300-400 ms for the five regions. \* indicates *p* \< 0.05.Fig. 4.

For the VS group, we found significant main effects of condition (F(1,8) = 8.37, *p* = 0.020) and region (F(1.1,9.1) = 16.12, *p* = 0.002) in the 0-100 ms time window. Furthermore, there was significant interaction between regions and conditions in the 300-400 ms (F(2.4,10.4) = 5.11, *p* = 0.012) time windows. As shown in [Fig. 4](#f0020){ref-type="fig"} (B), pairwise comparisons with multiple correction between pre-tDCS and post-tDCS in each region and time window showed significant excitability increase in left hemisphere (*p* = 0.045, FDR correction) during the 0-100 ms time window. However, there was significantly decreased excitability in frontal (*p* = 0.02, FDR correction) and left hemisphere (*p* = 0.037, FDR correction) during 300-400 ms.

Under sham stimulation, for all time windows, the main effect of condition and interaction of regions with condition were not significant in both the MCS and VS groups. But, it should be noted that all the comparison results above are only indicative trends which based on the samples in this study, and larger samples should be included confirm these trends in future studies.

Discussion {#s0025}
==========

Previous studies have reported effectiveness of using tDCS for clinical improvement of DOC ([@bb0005], [@bb0275]), but this therapy is still far from becoming an established clinical guideline. Assessment methods need to be developed to evaluate its treatment effects, and these methods will also facilitate the understanding of the mechanisms behind how tDCS alters consciousness states. In this study, TMS-EEG was used to assess the cortical excitability changes induced by tDCS on patients with DOC. In tDCS studies, left DLPFC are mainly considered site to be modulated in patients of DOC, and results suggested the patients could significantly benefit from the tDCS modulation at left DLPFC ([@bb0005], [@bb0275]). Besides, for patients of DOC, left DLPFC is always selected as target in other non-invasive modulation such as repetitive TMS ([@bb0165], [@bb0190]). Therefore, in this study, we targeted anodal tDCS at left DLPFC to explore its effects on cerebral excitability. Compared with sham stimulation, we found that 20mins of anodal tDCS of DLPFC could effectively modulate the GMFA of TEP both in MCS and VS patents, and these changes occurred in different time windows and brain regions for MCS and VS patients. For MCS patients, the GMFA were significantly increased within 200 ms after the TMS pulse, and all regions but posterior had significant reactivity. For VS patients, the tDCS affects mainly the 0-100 ms and 300-400 ms post-TMS time intervals. Changes mainly occurred in the frontal and left hemisphere. Comparing with sham stimulation allowed us to exclude the confounding influence of unspecific effects, such as the cortical state fluctuation of patients.

For the healthy subjects, anodal tDCS induced significant enhancement of cortical excitability, which was also represented by higher amplitude in TEP and GMFA ([@bb0210], [@bb0235]). When anodal tDCS delivered at right parietal, temple and spatial analysis showed that the enhancement significantly changed within 100 ms following TMS pulse and the altering could be found in bilateral frontal, parietal and right temporal ([@bb0235]). Consistent with the healthy subjects, we suggest that the significant change in TEP within the early time window (100 ms) for MCS and VS patients is directly caused by changes in the excitability of the DLPFC, and the changes occurring in other time windows may be caused by excitability changes in remote regions which interact with the DLPFC through ipsilateral and contralateral connectivity. This theory is supported by the following findings. The GMFA increases within early time windows were due to resting membrane potential increases caused by anodal tDCS stimulation ([@bb0015], [@bb0080]). Similar modulation of early TEP components have been demonstrated after rTMS ([@bb0060]), anesthesia ([@bb0065]), and electroconvulsive therapy ([@bb0035]). The cortical excitability decreases in the later time window of 300-400 ms for VS patients could be related to the overall cortical state or consciousness level. Considering the differences in clinical response to tDCS between patients with MCS and VS, this excitability decrease may be a marker of consciousness level. But, the statistic results were based on the limited samples in this study. Considering to confirm these trends, larger samples should be investigated in future studies.

Previous studies demonstrated that tDCS can be applied to modulate brain connectivity. In ([@bb0125], [@bb0215]), it was demonstrated that prefrontal tDCS could induce network connectivity change in healthy subjects; after anodal stimulation, increase of cortical response has been found not only over the stimulated cortex but also propagated to the contralateral homotopic areas ([@bb0260], [@bb0255]). It has also been reported that tDCS can modulate cortico-subcortical networks such as thalamo-cortical circuits ([@bb0225]). Unilateral anodal tDCS can affect inter-hemispheric interactions measured by TMS-EEG ([@bb0210], [@bb0235]). Consistent with previous studies ([@bb0125], [@bb0235], [@bb0265]), the GMFA and LMFA changes observed in this study indicate that the effects of tDCS can diffuse from underneath the stimulated area to other brain regions for patients with DOC. Previous research has demonstrated widespread impairment of fronto-central cortices in VS patients ([@bb0140]), and severe impairment of functional inter-regional connectivity has also been demonstrated in DOC patients ([@bb0240]). Since it is likely that cortical impairment may disrupt some cortico-cortical and cortico-subcortical connectivity, when we apply tDCS to the DLPFC of VS patients, we cannot obtain remote effects similar to healthy subjects.

Considering that patients with MCS generally have relatively less severe brain injury than VS, especially patient0s with MCS in better consciousness states, we may observe significant differences between MCS and VS patients in terms of excitability induced by tDCS. These differences depend on the injured connections in brain regions. Furthermore, we believe that tDCS modulation of the brain may be dependent on the underlying structural integrity of the cortical network.

Studies have demonstrated that short term tDCS can induce modulation of neuronal resting membrane potential and neuronal recruitment ([@bb0130], [@bb0205]). Long term tDCS can induce after-effects which are mediated by synaptic long-term potentiation and depression mechanisms, likely mediated by *N*-methyl-[d]{.smallcaps}-aspartate (NMDA) receptors and altering GABAergic activity and intra-cellular *CA*^2 +^ concentration ([@bb0160], [@bb0250]). The modulation is polarity dependent: anodal stimulation increases the spontaneous firing rate and cathodal stimulation decreases cortical excitability. The TEP in this study reflects reactivity of cortical neuronal populations to stimulation and is dependent on the complex interactions between both excitatory glutamatergic and inhibitory GABAergic neurotransmitters ([@bb0170]). Hence, by observing the amplitude variation in TEP, which represents a direct measure of the neuronal changes induced by tDCS, we infer that tDCS of DLPFC effectively modulates cortical excitation or depression circuits in patients with DOC by changing neurotransmitter activity.

TMS-EEG is a robust functional neuroimaging technique which can assess brain reactivity and connectivity with high temporal resolution in a relatively objective manner ([@bb0045], [@bb0230]), and this method has been applied in research on sleep ([@bb0175]), anesthesia ([@bb0065]), and DOC ([@bb0240]). In this study, we used TMS-EEG to evaluate the effects of tDCS on patients with DOC. TMS-EEG has the capability to shed light on both local and global brain network changes, which makes it valuable for understanding the underlying effects of and mechanisms behind tDCS of patients with DOC. It is known that current density and stimulation duration influence tDCS effects ([@bb0195]). Anatomical differences between patients and depth and orientation of cells within the cortex are also influencing factors on the modulatory effects ([@bb0030], [@bb0025]). Thus, more investigation is needed to optimize tDCS parameters, including current density, current output time, and position of anode and cathode. This study gives an example of using TMS-EEG to assess the electrophysiological effects of tDCS on patients with DOC. We believe that TMS-EEG is a promising technique for assessing the effectiveness of various tDCS parameters settings and target brain regions, as well as the effectiveness of other non-invasive brain stimulation techniques, such as transcranial alternating current stimulation, transcranial random noise stimulation. And repetitive transcranial magnetic stimulation.

Conclusion {#s0030}
==========

This is the first study to provide electrophysiological reactivity evidence that tDCS can modulate the cortical excitability of patients with DOC. We found differences in tDCS induced cortical excitability changes between MCS and VS patients using TMS-EEG. We believe TMS-EEG assessment can contribute to therapeutic trials for tDCS of patients with DOC. Lastly, this study provides an example of combining TMS-EEG with non-invasive brain stimulation to evaluate neuro-modulatory effects of stimulation in patients with DOC.
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TDCS = transcranial direct current stimulation

DOC = disorders of consciousness

VS = vegetative state

MCS = minimally conscious state

[^1]: Comm = communication; TBI = traumatic brain injury; CRS-R = Coma recovery scale-revised; f = female; m = male.
